Ocrevus (ocrelizumab) is an infusion therapy approved to treat adults with relapsing forms of MS and primary progressive MS. Administered via an intravenous infusion, the treatment is used to reduce the frequency of relapses, lower the number of lesions, and slow disability progression.

The post Ocrevus (ocrelizumab) for multiple sclerosis appeared first on Multiple Sclerosis News Today.

Source: multiplesclerosisnewstoday.com